Gianluigi Savarese, MD PhD, FESC, FHFA
Associate Professor of Cardiology
Department of Medicine
Karolinska Institutet, Stockholm, Sweden
Heart failure Cardiologist
Karolinska University Hospital, Stockholm, Sweden
Gianluigi Savarese is an Italian/Swedish cardiologist, currently Associate Professor of Cardiology at the Department of Medicine, Karolinska Institutet, Stockholm, Sweden and Consultant in Heart Failure at the Karolinska University Hospital, Stockholm, Sweden. He received his MD from Federico II University in Naples (Italy) in 2010 and underwent cardiology residency (2011-2016) at the same Institution. In 2013-2014 he was guest fellow at the Center for Molecular Cardiology of the University of Zurich (Switzerland) headed by Prof TF Luscher, where he investigated the molecular mechanisms of heart failure. In 2017 he got the title of heart failure specialist from the University of Zurich, the Heart Failure Association of the European Society of Cardiology and the European Heart Academy. In 2018 he received his PhD from the Karolinska Institutet (Stockholm-Sweden), with a thesis entitled “Biomarkers for eligibility and surrogate endpoints in heart failure trials”. He is currently fellow of the European Society of Cardiology (FESC) and of the Heart Failure Association (FHFA), former secretary and current board member of the ESC working group on cardiovascular pharmacotherapy and board member of the Heart Failure Association of the European Society of Cardiology.
Over the last 5 years, he has published more than 150 articles on top peer reviewed journals. Major focus in his research is heart failure, with a particular interest in phenotyping heart failure for improving clinical trial design. He is heavily involved in registry studies (Swedish Heart Failure Registry, HFA registries), clinical trials and he has several research collaborations in Europe and USA. He has worked as reviewer for several peer-reviewed journals (Nature, EHJ, EJHF, JACC, Annals of Internal Medicine, International Journal of Cardiology, Journal of Cardiovascular Medicine, Journal of Cardiac Failure, European Heart Journal – Cardiovascular Pharmacotherapy, etc) and he is currently editor for Frontiers, Plos One, European Heart Journal Open and and European Heart Journal – Case reports. He is expert in meta-analyses, big data analyses and registry-based research.